Clinical study of recombinant anti-tumor and anti-virus protein injection compared with placebo in metastatic colorectal cancer after failure of second-line and more than second-line treatment毛晓阳, 王岩, 林莉, 徐农, 熊建萍, 白莉, 沈琳, 刘巍, 徐建明673-678
Research of methylation of the LINE-1 promoter in peripheral plasma of hepatocellular carcinoma高旭东, 曲建慧, 何艳, 关雪, 冯帆, 王春平, 陆荫英, 白文林, 王鈜679-682
Preliminary study of the effects of β-elemene on breast cancer stem cells in cell line MCF-7/ADMLI Luan, DONG Yan, WANG Ling, GAO Yajie683-687
Expression of EML4-ALK in non-small cell lung cancer and its clinical significanceWANG Meng, YANG Jiyuan, LI Junchuan, CHEN Yanxuan688-690
Expression of miR-122 in hepatocellular carcinoma and its relationship with cell cycle regulationZHANG Ying, JIA Shaochang, XIANG Fang, LU Lei, WANG Xuan691-694
The expression and clinical significance of survivin and Ki-67 in non-hodgkin's lymphoma in oral and maxillofacial regionLIU Zhuoxing, LIU Wenling695-698
Analysis of intensity-modulated radiotherapy for untreated patients with nasopharyngeal carcinomaTANG Jianmin, MA Xiumei, HOU Yanli, DAI Liyan, CAO Hongbin, YE Ming, BAI Yongrui699-703
Clinical observation on XELOX regimen as systemic chemotherapy for advanced primary liver carcinoma杨柳青, 秦叔逵, 华海清, 龚新雷, 刘秀峰, 夏兆珺, 陈映霞, 王琳704-708
Clinical observation of forty-three advanced hepatocellular carcinoma patients treated with sorafenibWANG Nanya, ZHAO Hengjun, HE Hua, MIAO Fenghua, CUI Guozhen, LI Wei709-712
Clinical observation of CT-guided 125Ⅰ seed implantation on refractory metastatic liver cancerLI Baoguo, GUO Zhi, WANG Haitao, ZHANG Weihao713-717
